Keyphrases
Early Treatment
100%
Non-ketotic Hyperglycemia
100%
N-methyl-D-aspartate Receptor (NMDAR)
33%
Neonatal Period
33%
Developmental Milestones
33%
Prognosis Prediction
33%
Clinical Presentation
33%
Convulsion
33%
Neurological Deficit
33%
Neurological Complications
33%
Cerebrospinal Fluid
33%
Sodium Benzoate
33%
N-methyl-D-aspartate
33%
Overstimulation
33%
Glycine Receptor
33%
Glycine
33%
Receptor Modulators
33%
Psychomotor Retardation
33%
Neurological Conditions
33%
Medicine and Dentistry
Hyperglycinemia
100%
N Methyl-D-Aspartate Receptor
33%
Newborn Period
33%
Childbirth
33%
Mental Capacity
33%
Cerebrospinal Fluid
33%
Psychomotor Retardation
33%
Aspartic Acid
33%
Developmental Milestone
33%
Neurological Complication
33%
Benzoic Acid
33%
Glycine Receptor
33%
Neuroscience
Aspartic Acid
100%
Eicosanoid Receptor
50%
Benzoic Acid
50%
Glycine Receptor
50%
Receptor Modulator
50%
Psychomotor Retardation
50%
Pharmacology, Toxicology and Pharmaceutical Science
Hyperglycinemia
100%
Aspartic Acid
66%
Receptor
33%
Neurological Complication
33%
Benzoic Acid
33%
Glycine Receptor
33%
Psychomotor Retardation
33%